# Nicotine Pharmacokinetic Profile of the CHTP 1.1 M

> **NCT02466412** · NA · COMPLETED · sponsor: **Philip Morris Products S.A.** · enrollment: 56 (actual)

## Conditions studied

- Smoking

## Interventions

- **OTHER:** CHTP 1.1 M
- **OTHER:** mCC

## Key facts

- **NCT ID:** NCT02466412
- **Lead sponsor:** Philip Morris Products S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2015-08
- **Final completion:** 2015-11
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2020-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02466412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02466412, "Nicotine Pharmacokinetic Profile of the CHTP 1.1 M". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02466412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*